Table 1.
Group | Number | Sex | Race | Age (years) | PMI (h) | pH | RIN |
---|---|---|---|---|---|---|---|
Controls | 127 | 83M/44F | 75AA/47C/4AS/1H | 45 ± 14 | 33.2 ± 15.2 | 6.51 ± 0.28 | 8.19 ± 0.87 |
SZ patients | 76 | 50M/26F | 43AA/31C/2H | 51 ± 17 | 39.5 ± 22.9 | 6.39 ± 0.24 | 8.10 ± 0.92 |
BP patients | 20 | 10M/10F | 2AA/17C/1AS | 43 ± 12 | 28.0 ± 14.6 | 6.21 ± 0.17 | 8.17 ± 0.72 |
MDD patients | 43 | 22M/21F | 9AA/32C/1AS/1H | 41 ± 17 | 37.7 ± 25.6 | 6.23 ± 0.22 | 8.16 ± 0.77 |
Life span | 137 | 82M/55F | 78AA/54C/2AS/3H | 29 ± 23 | 25.7 ± 17.4 | 6.51 ± 0.29 | 8.34 ± 0.97 |
SZ, schizophrenia; BP, bipolar disorder; MDD, major depressive disorder; M, male; F, female; AA, African American; C, Caucasian; AS, Asian; H, Hispanic.